Metoprolol. [cited; Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Metoprolol. Accessed 10 Oct 2021.
Brogden RN, Heel RC, Speight TM, Avery GS. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1977;14(5):321–48.
Morris J, Dunham A. Metoprolol. Treasure Island: StatPearls Publishing; 2018.
Jorge R, Chaves L, da Silva CA, et al. Alternative management of circumscribed choroidal hemangioma using intravitreal metoprolol. Retinal Cases Brief Reports. 2022;16(1):106–10.
Tubic-Grozdanis M, Bolger MB, Langguth P, et al. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds. AAPS J. 2008;10(1):213–26.
CAS PubMed PubMed Central Article Google Scholar
Regårdh C-G, Johnsson G. Clinical pharmacokinetics of metoprolol. Clin Pharmacokinet. 1980;5(6):557–69.
Berger B, Bachmann F, Duthaler U, et al. Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug. Front Pharmacol. 2018;9:774.
PubMed PubMed Central Article CAS Google Scholar
Lukacova V, Woltosz WS, Bolger MB. Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data. AAPS J. 2009;11(2):323–34.
CAS PubMed PubMed Central Article Google Scholar
Brocker CN, Velenosi T, Flaten HK, et al. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genom. 2020;14(1):1–9.
Regårdh CG, Borg KO, Johansson R, et al. Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in man. J Pharmacokinet Biopharm. 1974;2(4):347–64.
Mateus A, Matsson PR, Artursson P. A high-throughput cell-based method to predict the unbound drug fraction in the brain. J Med Chem. 2014;57(7):3005–10.
CAS PubMed PubMed Central Article Google Scholar
Benfield P, Clissold SP, Brogden RN. Metoprolol. Drugs. 1986;31(5):376–429.
CAS PubMed Article Google Scholar
Neil-Dwyer G, Bartlett J, McAinsh J, et al. Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol. 1981;11(6):549–53.
CAS PubMed PubMed Central Article Google Scholar
Younis W, Asif H, Sharif A, et al. Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence. Chin Med. 2018;13(1):1–29.
Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17):2215–20.
Regårdh C-G, Jordö L, Ervik M, et al. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. Clin Pharmacokinet. 1981;6(5):375–88.
Jordö L, Attman P, Aurell M, et al. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. Clin Pharmacokinet. 1980;5(2):169–80.
Meloche M, Khazaka M, Kassem I, et al. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: a systematic review and meta-analysis. Br J Clin Pharmacol. 2020;86(6):1015–33.
CAS PubMed PubMed Central Article Google Scholar
Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www cochrane-handbook org. 2011.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.
Clark HD, Wells GA, Huët C, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 1999;20(5):448–52.
CAS PubMed Article Google Scholar
Al-Dirini RMA, Thewlis D, Paul G. A comprehensive literature review of the pelvis and the lower extremity FE human models under quasi-static conditions. Work. 2012;41(Supplement 1):4218–29.
Regårdh C-G, Johnsson G, Jordö L, et al. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol. J Cardiovasc Pharmacol. 1980;2(6):715–23.
Godbillon J, Evard D, Vidon N, et al. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol. 1985;19(S2):113S-S118.
CAS PubMed PubMed Central Article Google Scholar
Richard J, Cardot J, Godbillon J. Inter-and intra-subject variability of metoprolol kinetics after intravenous administration. Eur J Drug Metab Pharmacokinet. 1994;19(2):157–62.
CAS PubMed Article Google Scholar
Larsson M, Landahl S, Lundborg P, et al. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol. 1984;27(2):217–22.
CAS PubMed Article Google Scholar
Kendall M, John V, Quarterman C, et al. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. Eur J Clin Pharmacol. 1980;17(2):87–92.
CAS PubMed Article Google Scholar
Sandberg A, Blomqvist I, Jonsson U, et al. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets. Eur J Clin Pharmacol. 1988;33(1):S9–14.
CAS PubMed Article Google Scholar
Oosterhuis B, Jonkman J, Kerkhof F. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation. Eur J Clin Pharmacol. 1988;33(1):S15–8.
CAS PubMed Article Google Scholar
Oosterhuis B, Jonkman J, Zuiderwijk P, et al. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation. J Clin Pharmacol. 1990;30(S2):S33–8.
CAS PubMed Article Google Scholar
Wieselgren I, Lundborg P, Sandberg A, et al. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects. J Clin Pharmacol. 1990;30(S2):S28–32.
CAS PubMed Article Google Scholar
Lücker P, Moore G, Wieselgren I, et al. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses. J Clin Pharmacol. 1990;30(S2):S17–27.
Darmansjah I, Wong E, Setiawati A, et al. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol. J Clin Pharmacol. 1990;30(S2):S39–45.
CAS PubMed Article Google Scholar
Dimenäs E, Dahlöf C, Heibel B, et al. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects—a comparison with atenolol. Eur J Clin Pharmacol. 1990;38(6):571–8.
Lundborg P, Abrahamsson B, Wieselgren I, et al. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers. Eur J Clin Pharmacol. 1993;45(2):161–3.
CAS PubMed Article Google Scholar
Jin S, Chung H, Chung M, et al. Influence of CYP2D6* 10 on the pharmacokinetics of metoprolol in healthy Korean volunteers. J Clin Pharm Ther. 2008;33(5):567–73.
CAS PubMed Article Google Scholar
Luzier AB, Killian A, Wilton JH, et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 1999;66(6):594–601.
CAS PubMed Article Google Scholar
Cerqueira PM, Cesarino EJ, Mateus FH, et al. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients. Chirality. 1999;11(7):591–7.
CAS PubMed Article Google Scholar
Held P, Regårdh C-G. Metoprolol in acute myocardial infarction. A pharmacokinetic and pharmacodynamic study. Eur J Clin Pharmacol. 1986;31(3):261–5.
CAS PubMed Article Google Scholar
Everts B, Karlson B, Herlitz J, et al. Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction. Eur J Clin Pharmacol. 1997;53(1):23–31.
CAS PubMed Article Google Scholar
Kendall M, Quarterman C, Jack D, et al. Metoprolol pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol. 1982;14(1):120.
CAS PubMed PubMed Central Article Google Scholar
Jack DB, Kendall MJ, Dean S, et al. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol. Biopharm Drug Dispos. 1982;3(1):47–54.
留言 (0)